Roadmap and Milestones

Linker Sciences has established the following roadmap to execute its dual strategy of platform licensing and internal drug pipeline validation. Our build-out is staged, capital-efficient, and designed to scale, with each core adding measurable value and reducing discovery risk.

• Data Analytic Core (Developed): based on a validated comprehensive untargeted metabolomics pipeline now positioned for significant improvements and rapid deployment. This core will serve as the analytic engine for untargeted affinity screening data processing and hit triage using predicted IC₅₀ once integrated.

• Bioanalytical Mass Spectrometry Core (In Progress): upcoming lab setup and NPL kit development milestones.

• Biology Core (Planned): marine and synthetic biology programs for BDL kit development.

• Medicinal Chemistry Core (Pending Build-Out): future SAR optimization and lead development using SCL kits.

We designed this stepwise progression to create near-term opportunities for collaboration while building long-term value.